Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit D Parulekar

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Annals of Translational Medicine|March 11, 2020
Is perfusate exchange during <i>ex vivo</i> lung perfusion beneficial?Christina C Kao, Amit D Parulekar
Journal of Thoracic Disease|October 22, 2019
Postoperative management of lung transplant recipientsChristina C Kao, Amit D Parulekar
Journal of Thoracic Disease|October 22, 2019
Detection, classification, and management of rejection after lung transplantationAmit D Parulekar, Christina C Kao
Journal of Asthma and Allergy|January 22, 2019
Spotlight on fevipiprant and its potential in the treatment of asthma: evidence to dateChristina C Kao, Amit D Parulekar
Journal of Hospital Medicine|March 31, 2015
Hospital management of acute exacerbations of chronic obstructive pulmonary diseaseLeonard Chow, Amit D Parulekar, Nicola A Hanania
Journal of Thrombosis and Thrombolysis|March 4, 2021
Need for anticoagulation and use of direct oral anticoagulants in lung transplant recipientsChristina C Kao, Tai Wang, Amit D Parulekar
Expert Opinion on Biological Therapy|May 11, 2016
Lebrikizumab in the treatment of asthmaStephen Bujarski, Amit D Parulekar, Nicola A Hanania
Current Opinion in Pulmonary Medicine|November 18, 2015
Role of T2 inflammation biomarkers in severe asthmaAmit D Parulekar, Zuzana Diamant, Nicola A Hanania
Current Opinion in Pulmonary Medicine|November 22, 2014
Antifungals in severe asthmaAmit D Parulekar, Zuzana Diamant, Nicola A Hanania
European Journal of Clinical Pharmacology|August 18, 2020
Tacrolimus monitoring parameters are not associated with acute cellular rejection following lung transplantationChristina C Kao, Justin Segraves, Amit D Parulekar
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Annals of Translational Medicine|March 11, 2020
Is perfusate exchange during <i>ex vivo</i> lung perfusion beneficial?Christina C Kao, Amit D Parulekar
Journal of Thoracic Disease|October 22, 2019
Postoperative management of lung transplant recipientsChristina C Kao, Amit D Parulekar
Journal of Thoracic Disease|October 22, 2019
Detection, classification, and management of rejection after lung transplantationAmit D Parulekar, Christina C Kao
Journal of Asthma and Allergy|January 22, 2019
Spotlight on fevipiprant and its potential in the treatment of asthma: evidence to dateChristina C Kao, Amit D Parulekar
Journal of Hospital Medicine|March 31, 2015
Hospital management of acute exacerbations of chronic obstructive pulmonary diseaseLeonard Chow, Amit D Parulekar, Nicola A Hanania
Journal of Thrombosis and Thrombolysis|March 4, 2021
Need for anticoagulation and use of direct oral anticoagulants in lung transplant recipientsChristina C Kao, Tai Wang, Amit D Parulekar
Expert Opinion on Biological Therapy|May 11, 2016
Lebrikizumab in the treatment of asthmaStephen Bujarski, Amit D Parulekar, Nicola A Hanania
Current Opinion in Pulmonary Medicine|November 18, 2015
Role of T2 inflammation biomarkers in severe asthmaAmit D Parulekar, Zuzana Diamant, Nicola A Hanania
Current Opinion in Pulmonary Medicine|November 22, 2014
Antifungals in severe asthmaAmit D Parulekar, Zuzana Diamant, Nicola A Hanania
European Journal of Clinical Pharmacology|August 18, 2020
Tacrolimus monitoring parameters are not associated with acute cellular rejection following lung transplantationChristina C Kao, Justin Segraves, Amit D Parulekar
Pageof 4